0000874015-23-000010.txt : 20230105
0000874015-23-000010.hdr.sgml : 20230105
20230105181150
ACCESSION NUMBER: 0000874015-23-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230105
DATE AS OF CHANGE: 20230105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baroldi Joseph
CENTRAL INDEX KEY: 0001813775
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 23512830
MAIL ADDRESS:
STREET 1: C/O AVIDITY BIOSCIENCES, INC.
STREET 2: 10975 N. TORREY PINES RD., SUITE 150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2023-01-03
0
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001813775
Baroldi Joseph
2855 GAZELLE COURT
CARLSBAD
CA
92010
0
1
0
0
EVP, Chief Business Officer
Non-Qualified Stock Option (right to buy)
37.58
2023-01-03
4
A
0
19665
0.0
A
2024-01-03
2033-01-02
Common Stock
19665
19665
D
Non-Qualified Stock Option (right to buy)
37.58
2023-01-03
4
A
0
2400
0.0
A
2024-01-03
2033-01-02
Common Stock
2400
2400
I
by Spouse
Grant on 01/03/2023 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on
01/03/2023. 25% of the shares subject to the option will vest and become exercisable on 01/03/2024. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
Grant on 01/03/2023 to reporting person's spouse of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on
01/03/2023. 25% of the shares subject to the option will vest and become exercisable on 01/03/2024. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years.
By: Patrick R. O'Neil, attorney-in-fact For: Joseph T. Baroldi
2023-01-04